See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The U.S. Food and Drug Administration (FDA) has approved a new drug for ...

BAKERSFIELD, Calif. (KGET) – The FDA has approved a new non-opioid painkiller, a potentially significant step in the ...

Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but it's expensive. Reading time 2 minutes To treat acute pain, doctors in the U ...

The Food and Drug Administration is requiring pharma companies selling opioid pain medications to “better emphasize and explain the risks associated with their long-term use” on medication labels, the ...

With the goal of informing clinician practice, a new study explores the harms and benefits of continuing and of discontinuing the long-term prescription of opioid medicines to adults with chronic pain ...

Rising surgeries and opioid safety concerns are accelerating multimodal, non-opioid pain care, creating opportunities for safer parenteral drugs and novel delivery systems.Dublin, Sept. 24, 2026 ...

For a patient having their wisdom teeth removed, the days after surgery can bring an important question: How much pain medication will I actually need?

Using medical marijuana helps people who suffer from lower pain significantly reduce their opioid use as well as experience ...

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug Administration (FDA). The company’s "first-in-class" suzetrigine pain pill received ...

Women giving birth in rural areas were more likely than urban peers to receive opioid prescriptions upon leaving the hospital after a C-section.

(The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval is an ...